Cohen Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Cohen Investment Advisors's PFE Position: Q1 2026 in Review
Cohen Investment Advisors increased its Pfizer (PFE) stake by 2.5% in Q1 2026, buying an estimated $80.7K and bringing the position to 121,990 shares worth $3.43M. The position accounts for 1.63% of the portfolio, ranked #30.
Cohen Investment Advisors first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.53M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Cohen Investment Advisors held 121,990 shares of Pfizer worth $3.43M as of Q1 2026.
- Cohen Investment Advisors bought 3,030 Pfizer shares in Q1 2026, an estimated $80.7K.
- Pfizer made up 1.63% of Cohen Investment Advisors's portfolio in Q1 2026, its #30 holding.
- Cohen Investment Advisors first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
- Cohen Investment Advisors's Pfizer position peaked at $3.53M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Cohen Investment Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.